Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG

Prostate

Volumn 72, Issue 4, 2012, Pages 410-426

  Lu, Lingyi ^a   Cancel Tassin, Geraldine ^b   Valeri, Antoine ^b   Cussenot, Olivier ^b   Lange, Ethan M ^c,d   Cooney, Kathleen A ^c,e   Farnham, James M ^f   Camp, Nicola J ^f   Cannon Albright, Lisa A ^f   Tammela, Teuvo L J ^g   Schleutker, Johanna ^g   Hoegel, Josef ^h   Herkommer, Kathleen ^h,i   Maier, Christiane ^h,i   Vogel, Walther ^h   Wiklund, Fredrik ^j   Emanuelsson, Monica ^j,k   Grönberg, Henrik ^j   Wiley, Kathleen E ^l   Isaacs, Sarah D ^l   Walsh, Patrick C ^l   Helfand, Brian T ^m   Kan, Donghui ^m   Catalona, William J ^m   Stanford, Janet L ⁿ   Fitzgerald, Liesel M ⁿ   Johanneson, Bo ^n,o   Deutsch, Kerry ^n,p   McIntosh, Laura ⁿ   Ostrander, Elaine A ^n,o   Thibodeau, Stephen N ^q   McDonnell, Shannon K ^q   Hebbring, Scott ^q   Schaid, Daniel J ^q   Whittemore, Alice S ^r,s,t   Oakley Girvan, Ingrid ^r,t   Hsieh, Chih Lin ^r,u   Powell, Isaac ^v,w   Bailey Wilson, Joan E ^g,v,x   Cropp, Cheryl D ^g,x   Simpson, Claire ^g,x   Carpten, John D ^v,y   Seminara, Daniela ^z   Zheng, S Lilly ^a   Xu, Jianfen ^a   Giles, Graham G ^aa,ab   Severi, Gianluca ^aa,ab   Hopper, John L ^aa,ac   English, Dallas R ^aa,ac   Foulkes, William D ^aa,ad   Maehle, Lovise ^aa,ae   Moller, Pal ^aa,ae   Badzioch, Michael D ^aa,af   Edwards, Steve ^aa,ag   Guy, Michelle ^aa,ag   Eeles, Ros ^aa,ag   Easton, Douglas ^aa,ah   Isaacs, William B ^l   more..

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^h UNIVERSITY OF ULM   (Germany)

ⁱ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^j KAROLINSKA INSTITUTE   (Sweden)

^k UMEÅ UNIVERSITY   (Sweden)

^l JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m NORTHWESTERN UNIVERSITY   (United States)

ⁿ USA   (United States)

^o NATIONAL INSTITUTES OF HEALTH   (United States)

^p INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^q Mayo Clinic ICPCG Group   (United States)

^r BC/CA/HI ICPCG Group   (United States)

^s STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^t STANFORD CANCER INSTITUTE   (United States)

^u UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^v African American Hereditary Prostate Cancer ICPCG Group   (United States)

^w WAYNE STATE UNIVERSITY   (United States)

^x NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^y TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^z NATIONAL CANCER INSTITUTE   (United States)

^aa ACTANE Consortium ICPCG Group   (Australia)

^ab CANCER EPIDEMIOLOGY CENTRE   (Australia)

^ac UNIVERSITY OF MELBOURNE   (Australia)

^ad MCGILL UNIVERSITY   (Canada)

^ae OSLO UNIVERSITY HOSPITAL   (Norway)

^af UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^ag INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^ah IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

more..

Author keywords

8q24; hereditary; prostate cancer; susceptibility

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CHROMOSOME 17Q; CHROMOSOME 22; CHROMOSOME 4; CHROMOSOME 5Q; CHROMOSOME 8; CHROMOSOME 8Q; DISEASE COURSE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOME; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MICROSATELLITE MARKER; PRIORITY JOURNAL; PROSTATE CANCER; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CHROMOSOMES, HUMAN, PAIR 4; CHROMOSOMES, HUMAN, PAIR 8; DATA INTERPRETATION, STATISTICAL; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; INTERNATIONAL COOPERATION; LOD SCORE; MALE; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS;

EID: 84856037428     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21443     Document Type: Article

References (41)

1. Easton DF, Eeles RA,. Genome-wide association studies in cancer. Hum Mol Genet 2008; 17 (R2): R109-R115.
2. Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P,. Relative risk of prostate cancer for men with affected relatives: Systematic review and meta-analysis. Int J Cancer 2003; 107 (5): 797-803. (Pubitemid 37339734)
3. Johns LE, Houlston RS,. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 2003; 91 (9): 789-794. (Pubitemid 36724060)
4. Easton DF, Schaid DJ, Whittemore AS, Isaacs WB,. International Consortium for Prostate Cancer Genetics. Where are the prostate cancer genes? A summary of eight genome wide searches. Prostate 2003; D57 (4): 261-269. (Pubitemid 37487071)
5. Schaid DJ,. The complex genetic epidemiology of prostate cancer. Hum Mol Genet 2004; 13: R103-R121. (Pubitemid 38443804)
6. Langeberg WJ, Isaacs WB, Stanford JL,. Genetic etiology of hereditary prostate cancer. Front Biosci 2007; 12: 4101-4110.
7. Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Eeles RA, Easton DF, Foulkes WD, Simar J, et al. A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet 2005; 77 (2): 219-229. (Pubitemid 41022705)
8. Bergerheim US, Kunimi K, Collins VP, Ekman P,. Deletion mapping of chromosomes 8, 10 and 16 in human prostatic carcinoma. Genes Chromosomes Cancer 1991; 3 (3): 215-220.
9. Bova GS, Carter BS, Bussemakers MJ, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC, et al. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 1993; 53 (17): 3869-3873. (Pubitemid 23267679)
10. El Gammal AT, Brüchmann M, Zustin J, Isbarn H, Hellwinkel OJ, Köllermann J, Sauter G, Simon R, Wilczak W, Schwarz J, et al. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer. Clin Cancer Res 2010; 16 (1): 56-64.
11. Tsuchiya N, Slezak JM, Lieber MM, Bergstralh EJ, Jenkins RB,. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer. Genes Chromosomes Cancer 2002; 34 (4): 363-371. (Pubitemid 34787457)
12. Sun J, Liu W, Adams TS, Sun J, Li X, Turner AR, Chang B, Kim JW, Zheng SL, Isaacs WB, Xu J,. DNA copy number alterations in prostate cancers: A combined analysis of published CGH studies. Prostate 2007; 67 (7): 692-700. (Pubitemid 46709438)
13. Xu J, Zheng SL, Hawkins GA, Faith DA, Kelly B, Isaacs SD, Wiley KE, Chang B, Ewing CM, Bujnovszky P, et al. Linkage and association studies of prostate cancer susceptibility: Evidence for linkage at 8 p22-23. Am J Hum Genet 2001; 69 (2): 341-350. (Pubitemid 32695206)
14. Wiklund F, Jonsson BA, Göransson I, Bergh A, Grönberg H,. Linkage analysis of prostate cancer susceptibility: Confirmation of linkage at 8 p22-23. Hum Genet 2003; 112 (4): 414-418. (Pubitemid 36869071)
15. Matsui H, Suzuki K, Ohtake N, Nakata S, Takeuchi T, Yamanaka H, Inoue I,. Genomewide linkage analysis of familial prostate cancer in the Japanese population. J Hum Genet 2004; 49 (1): 9-15. (Pubitemid 38186119)
16. Schaid DJ, Guenther JC, Christensen GB, Hebbring S, Rosenow C, Hilker CA, McDonnell SK, Cunningham JM, Slager SL, Blute ML, et al. Comparison of microsatellites versus single-nucleotide polymorphisms in a genome linkage screen for prostate cancer susceptibility Loci. Am J Hum Genet 2004; 75: 948-965. (Pubitemid 39532066)
17. Maier C, Herkommer K, Hoegel J, Vogel W, Paiss T,. A genomewide linkage analysis for prostate cancer susceptibility genes in families from Germany. Eur J Hum Genet 2005; 13 (3): 352-360. (Pubitemid 40360791)
18. Eeles RA, Kote-Jarai, Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 2009; 41 (10): 1116-1121.
19. Al Olama AA, Kote-Jarai Z, Giles GG, Guy M, Morrison J, Severi G, Leongamornlert DA, Tymrakiewicz M, Jhavar S, Saunders E, et al. Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet 2009; 41 (10): 1058-1060.
20. Yeager M, Chatterjee N, Ciampa J, Jacobs KB, Gonzalez-Bosquet J, Hayes RB, Kraft P, Wacholder S, Orr N, Berndt S, et al. Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet 2009; 41 (10): 1055-1057.
21. Gudmundsson J, Sulem P, Gudbjartsson DF, Blondal T, Gylfason A, Agnarsson BA, Benediktsdottir KR, Magnusdottir DN, Orlygsdottir G, Jakobsdottir M, et al. Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet 2009; 41 (10): 1122-1126.
22. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Cazier JB, Sainz J, et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 2006; 38: 652-658. (Pubitemid 43927306)
23. Camp NJ, Farnham JM, Allen-Brady K, Cannon-Albright LA,. Statistical recombinant mapping in extended high-risk Utah pedigrees narrows the 8q24 prostate cancer locus to 2.0 Mb. Prostate 2007; 67 (13): 1456-1464. (Pubitemid 47435792)
24. Fleming WH, Hamel A, MacDonald R, Ramsey E, Pettigrew NM, Johnston B, Dodd JG, Matusik RJ,. Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia. Cancer Res 1986; 46: 1535-1538. (Pubitemid 16048309)
25. Gurel B, Iwata T, Koh CM, Jenkins RB, Lan F, Van Dang C, Hicks JL, Morgan J, Cornish TC, Sutcliffe S, et al. Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. Mod Pathol 2008; 21 (9): 1156-1167.
26. Jenkins RB, Qian J, Lieber MM, Bostwick DG,. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res 1997; 57: 524-530.
27. Sato K, Qian J, Slezak JM, Lieber MM, Bostwick DG, Bergstralh EJ, Jenkins RB,. Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma. J Natl Cancer Inst 1999; 91: 1574-1580. (Pubitemid 29457963)
28. Ellwood-Yen K, Graeber TG, Wongvipat J, Iruela-Arispe ML, Zhang J, Matusik R, Thomas GV, Sawyers CL,. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 2003; 4 (3): 223-238. (Erratum in: Cancer Cell. 2005 Dec; 8(6) 485). (Pubitemid 37163836)
29. Williams K, Fernandez S, Stien X, Ishii K, Love HD, Lau YF, Roberts RL, Hayward SW,. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype. Prostate 2005; 63 (4): 369-384. (Pubitemid 40664349)
30. Tuupanen S, Turunen M, Lehtonen R, Hallikas O, Vanharanta S, Kivioja T, Björklund M, Wei G, Yan J, Niittymäki I, et al. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet 2009; 41 (8): 885-890.
31. Pomerantz MM, Ahmadiyeh N, Jia L, Herman P, Verzi MP, Doddapaneni H, Beckwith CA, Chan JA, Hills A, Davis M, et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet 2009; 41 (8): 882-884.
32. Jia L, Landan G, Pomerantz M, Jaschek R, Herman P, Reich D, Yan C, Khalid O, Kantoff P, Oh W, et al. Functional enhancers at the gene-poor 8q24 cancer-linked locus. PLoS Genet 2009; 5 (8): e1000597.
33. Ahmadiyeh N, Pomerantz MM, Grisanzio C, Herman P, Jia L, Almendro V, He HH, Brown M, Liu XS, Davis M, et al. 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc Natl Acad Sci USA 2010; 107 (21): 9742-9746.
34. Sotelo J, Esposito D, Duhagon MA, Banfield K, Mehalko J, Liao H, Stephens RM, Harris TJ, Munroe DJ, Wu X,. Long-range enhancers on 8q24 regulate c-Myc. Proc Natl Acad Sci USA 2010; 107 (7): 3001-3005.
35. Stanford JL, FitzGerald LM, McDonnell SK, Carlson EE, McIntosh LM, Deutsch K, Hood L, Ostrander EA, Schaid DJ,. Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage. Hum Mol Genet 2009; 18 (10): 1839-1848.
36. Schaid DJ, Chang BL,. International Consortium For Prostate Cancer Genetics. Description of the International Consortium For Prostate Cancer Genetics, and failure to replicate linkage of hereditary prostate cancer to 20q13. Prostate 2005; 63 (3): 276-290. (Pubitemid 40571062)
37. Schaid DJ, McDonnell SK, Zarfas KE, Cunningham JM, Hebbring S, Thibodeau SN, Eeles RA, Easton DF, Foulkes WD, Simard J, et al. Pooled genome linkage scan of aggressive prostate cancer: Results from the International Consortium for Prostate Cancer Genetics. Hum Genet 2006; 120 (4): 471-485. (Pubitemid 44669782)
38. Abecasis GR, Cherny SS, Cookson WO, Cardon LR,. Merlin-Rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30 (1): 97-101.
39. Bhat A, Heath SC, Ott J,. Heterogeneity for multiple disease loci in linkage analysis. Hum Hered 1999; 49 (4): 229-231. (Pubitemid 29373682)
40. Kong A, Cox NJ,. Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 1997; 61 (5): 1179-1188. (Pubitemid 27492328)
41. Kumar-Sinha C, Tomlins SA, Chinnaiyan AM,. Recurrent gene fusions in prostate cancer. Nat Rev Cancer 2008; 8 (7): 497-511.